BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kawanishi T, Arakawa H, Masuo Y, Nakamichi N, Kato Y. Bile Duct Obstruction Leads to Increased Intestinal Expression of Breast Cancer Resistance Protein With Reduced Gastrointestinal Absorption of Imatinib. Journal of Pharmaceutical Sciences 2019;108:3130-7. [DOI: 10.1016/j.xphs.2019.05.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Arakawa H, Sugiura S, Kawanishi T, Shin K, Toyoda H, Satoh T, Sakai Y, Kanamori T, Kato Y. Kinetic analysis of sequential metabolism of triazolam and its extrapolation to humans using an entero-hepatic two-organ microphysiological system. Lab Chip 2020;20:537-47. [PMID: 31930237 DOI: 10.1039/c9lc00884e] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
2 Li Y, Yang B, Zhang X. Oral delivery of imatinib through galactosylated polymeric nanoparticles to explore the contribution of a saccharide ligand to absorption. Int J Pharm 2019;568:118508. [PMID: 31299337 DOI: 10.1016/j.ijpharm.2019.118508] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]